ImmuneBridge Company
ImmuneBridge is developing allogeneic immunotherapies for cancer.
Technology:
Cell therapy
Industry:
Private
Headquarters:
San Francisco, California, United States
Founded Date:
2018-01-01
Employees Number:
1-10
Investors Number:
1
Total Funding:
10150000
Last Funding Date:
2023-01-09
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership